Zacks Investment Research
06 Nov 2026, 17:50 UTC · 1h ago
Agenus' Q3 Earnings Match Estimates, Revenues Miss Mark, Stock Down
Impact · against what's priced in
Agenus faces mild downward pressure following a 10% revenue miss in Q3 2026, though this is partially offset by new marketing approvals in Armenia. The market's immediate reaction was negative, but the confirmed cash runway through Q3 2027 provides a stable operational baseline.
- AGEN−0.10
No priced-in read yet
- In context
The company missed revenue estimates by $3.5 million (10%), though it secured new marketing approvals for Botvymo and Evamplix in Armenia and confirmed a cash runway through Q3 2027.
Read from the article alone
